A case study on triple vessel coronary artery disease with dilated cardiomyopathy and reduced ejection fraction undergoing PCI and stenting to the mid right coronary artery

Janani1*, Prema2, Sri Preethi 3, Jayamenon4

1Staff nurse, Kauvery Hospital, Heartcity, Trichy, Tamil Nadu

2 Nursing In-charge, Kauvery Hospital, Heartcity, Trichy, Tamil Nadu

3Nurse Educator, Kauvery Hospital, Heartcity, Trichy, Tamil Nadu

4 Nursing Superintendent, Kauvery Hospital, Heartcity, Trichy, Tamil Nadu

*Correspondence

Abstract:

Coronary artery disease (CAD) is one of the major causes of cardiovascular morbidity and mortality worldwide. This case study describes the clinical management and nursing care of a 52-year-old female patient diagnosed with triple-vessel coronary artery disease, dilated cardiomyopathy, heart failure with reduced ejection fraction (HFrEF), and diabetes mellitus. The patient had a history of cardiovascular disease and was found to have severe coronary artery narrowing on coronary angiography. Echocardiographic findings showed reduced left-ventricular systolic function with an ejection fraction of approximately 35%. Coronary angiography revealed triple-vessel disease with a critical stenotic lesion in the mid right coronary artery. The patient underwent successful percutaneous coronary intervention (PCI) with drug-eluting stent placement in the mid RCA and balloon angioplasty of the proximal RCA. No immediate procedural complications were documented. This case highlights the importance of timely intervention and comprehensive multidisciplinary nursing management in patients with complex cardiac conditions.

Keywords: Coronary artery disease; Triple vessel disease; Dilated cardiomyopathy; Heart failure; Reduced ejection fraction; Percutaneous coronary intervention; Drug-eluting stent; Triple-vessel disease refers to significant narrowing involving all three major coronary artery systems. It can lead to myocardial ischemia, myocardial infarction, and heart failure.

Introduction

Coronary artery disease (CAD) is a condition in which the coronary arteries become narrowed or blocked due to the accumulation of atherosclerotic plaques. This reduces blood supply and oxygen delivery to the heart muscle. Triple-vessel disease refers to significant narrowing involving all three major coronary artery systems. It can lead to myocardial ischemia, myocardial infarction, and heart failure. Dilated cardiomyopathy is a condition characterized by enlargement of the heart chambers and impaired contraction of the heart muscle. It may result in reduced left ventricular ejection fraction. Heart failure with reduced ejection fraction (HFrEF) occurs when the heart cannot pump blood effectively. An ejection fraction of approximately 35% indicates reduced left ventricular systolic function. Percutaneous coronary intervention (PCI) is a minimally invasive procedure used to restore blood flow through narrowed coronary arteries by balloon angioplasty and stent placement.

Clinical Presentation

  • Admitted for planned PCI to the right coronary artery.
  • History of cardiovascular disease.
  • History of myocardial infarction
  • Associated history of heart failure.
  • During the hospital stay, the patient developed fever, chills, abdominal pain, and episodes of vomiting.
  • Subsequently complained of headache and localized lower back pain.

Diagnosis

Primary diagnosis

  • Coronary artery disease (CAD) – Triple vessel disease.
  • Critical stenosis of the mid right coronary artery.
  • Dilated cardiomyopathy.
  • Heart failure with reduced ejection fraction (HFrEF).
  • Left ventricular systolic dysfunction (EF 35%)

Associated conditions

  • Diabetes mellitus.
  • Systemic hypertension.
  • History of ST-elevation myocardial infarction (STEMI).
  • Tietze syndrome.
  • L3–L5 lumbar spondylolisthesis

Investigations

  • 12-lead ECG.
  • Complete blood count (CBC).
  • Renal function test (RFT).
  • Serum electrolytes.
  • Fasting and postprandial blood glucose.
  • HbA1c.

ECG

A case study on triple vessel coronary artery disease with dilated cardiomyopathy and reduced ejection fraction undergoing PCI and stenting to the mid right coronary artery - figure 1

ECHO

Impression-

  • Calcific & De-Generative Aortic Valve
  • Moderate AS
  • Mod.LV dysfunction
  • Grade II Diastolic dysfunction
  • Posterior Mitral Annular Calcification
  • Mild MR
  • Left ventricular systolic dysfunction (EF 35%)

Medical management

  • Losar 25 mg Losartan – angiotensin receptor blocker
  • Razo 20 mg Rabeprazole – reduces gastric acid secretion
  • Dapavel 10 mg
  • Duzela 30 mg Duloxetine – SNRI medication
  • Shelcal XT Calcium and vitamin D supplementation

Nursing management

  • Risk for bleeding related to antiplatelet therapy and PCI
  • Observe the radial puncture site.
  • Monitor for bleeding and hematoma.
  • Assess distal circulation.
  • Monitor hemoglobin and platelet count when prescribed.
  • Educate the patient not to stop antiplatelet medications without medical advice.
  • Monitor blood glucose regularly.
  • Administer prescribed antidiabetic medications.
  • Encourage diabetic diet.
  • Observe for signs of hypoglycemia and hyperglycemia.
  • Encourage regular follow-up.
  • Teach warning signs require immediate medical attention.

Percutaneous Coronary Intervention (PCI) –Successful PCI stenting to mid RCA on

04/11/2026.

Procedure details

  • The right radial artery was used as the vascular access site.
  • A 6 French sheath was used.
  • A JR 3.5 6F guiding catheter was introduced.
  • A 0.014-inch Run-through guidewire was passed across the lesion.
  • Pre dilatation was performed using a 2 × 10 mm semi-compliant balloon at 8 atmospheres for 15 seconds.
  • A 3 × 10 mm drug-eluting stent was deployed in the mid RCA at 12 atmospheres for 15 seconds.
  • Post-dilatation was performed using a 3.25 × 10 mm non-compliant balloon.
  • Proximal RCA lesion balloon angioplasty was also performed.
  • Final coronary angiography showed good TIMI flow with a well-expanded stent.

Outcome

  • The patient underwent successful PCI and drug-eluting stent placement to the mid RCA.
  • Final angiography demonstrated good TIMI flow.
  • No immediate procedural complications were documented.
  • Post-procedure vital signs were monitored.
  • Episodes of fever, vomiting, and abdominal discomfort were assessed and managed as documented.
  • The patient was encouraged to follow the prescribed medication and dietary plan.
  • Continued cardiac follow-up and monitoring were advised.

Conclusion

Coronary artery disease with triple-vessel involvement and dilated cardiomyopathy is a serious cardiac condition that requires timely diagnosis, appropriate medical treatment, and interventional management. In this case, the patient had reduced left ventricular ejection fraction of approximately 35% and critical stenosis of the mid right coronary artery. Successful PCI with drug-eluting stent placement restored satisfactory coronary blood flow. Comprehensive nursing management played an important role in monitoring cardiovascular status, preventing complications, administering medications, and educating the patient. Patient education, medication adherence, lifestyle modification, diabetic control, and regular cardiac follow-up are essential for improving outcomes and quality of life. Triple-vessel disease refers to significant narrowing involving all three major coronary artery systems. It can lead to myocardial ischemia, myocardial infarction, and heart failure.

References

  1. American Diabetes Association Professional Practice Committee. (2025). 10. Cardiovascular disease and risk management: Standards of Care in Diabetes—2025. Diabetes Care, 48(Supplement 1).
  2. Heidenreich, P. A., et al. (2022). 2022 AHA/ACC/HFSA guideline for the management of heart failure. Circulation, 145(18), e895–e1032. https://doi.org/10.1161/CIR.0000000000001063
  3. Lawton, J. S., et al. (2022). 2021 ACC/AHA/SCAI guideline for coronary artery revascularization. Circulation, 145(3), e18–e114. https://doi.org/10.1161/CIR.0000000000001038
  4. Virani, S. S., et al. (2023). 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease. Circulation, 148(9), e9–e119. https://doi.org/10.1161/CIR.0000000000001168
Kauvery Hospital